Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Domestic Revenue	144.43B	135.18B	114.57B
Domestic Revenue Growth	6.84%	17.99%	-25.96%
Europe Revenue	3.06T	2.96T	2.35T
Europe Revenue Growth	3.22%	25.89%	31.80%
USA Revenue	1.55T	1.17T	971.06B
USA Revenue Growth	32.00%	20.91%	13.71%
Other Geographic Revenue	278.82B	274.75B	255.12B
Other Geographic Revenue Growth	1.48%	7.70%	23.43%

Revenue Breakdown

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Contract Development and Manufacturing Organization (CDMO) Revenue	3.01T	2.67T
Contract Development and Manufacturing Organization (CDMO) Revenue Growth	12.54%	14.41%
Biopharmaceutical Development and Commercialization Revenue	1.54T	1.02T
Biopharmaceutical Development and Commercialization Revenue Growth	50.71%	53.71%

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Contract Development and Manufacturing Organization (CDMO) Operating Profit	1.12T	1.09T
Contract Development and Manufacturing Organization (CDMO) Operating Profit Growth	2.86%	18.86%
Biopharmaceutical Development and Commercialization Operating Profit	200.69B	25.46B
Biopharmaceutical Development and Commercialization Operating Profit Growth	688.24%	-62.58%

Updated Jun 30, 2025. Data Source: Fiscal.ai.